Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Hypernatraemia and diuretics
2013-002165-19Phase 3Active
- Sponsor
- Medisch Centrum Leeuwarden
- Start
- Jul 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of captopril + hydrochlorothiazide in hypernatremia, sponsored by Medisch Centrum Leeuwarden. Primary endpoint: Plasma sodium reduction. Started Jul 2013; status: active.
02
Drugs
captopril + hydrochlorothiazide
03
Conditions
hypernatremia
Beyond the preview
Go deeper on 2013-002165-19.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2013-002165-19.